Principal Investigator
Sangeetha Venugopal
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20230633
Clinical Trial Summary
An escalation/expansion, Open label, Multicenter study of iadademstat and gilteritinib in patients with Relapsed or Refractory Acute Myeloid Leukemia (R/R AML) with FMS-like tyrosine kinase mutation (FLT3 mut+): The FRIDA Study/ CL04-ORY-1001
Phase
Phase I
Funding Agency/Sponsor
Industrial
Disease
Leukemia/heme
Contact Information
Phone Number
305-243-2647